  See all
 |
Articles: Myeloproliferative Dz |
Prior Articles
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
Annals of Oncology, 06/02/09
Free full text
Revew Article
JAK2V617F-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease
Acta Haematologica, 06/01/09 Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
Blood, 05/29/09 Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States
Cancer Causes and Control, 05/29/09 The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies
European Journal of Cancer, 05/29/09 Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome
International Journal of Hematology, 05/28/09 Myelodysplastic syndromes: classification and prognostic scoring systems and their applicability in Indian scenario-experience from a tertiary care center
Hematology, 05/28/09 Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy
The Oncologist, 05/27/09 Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial
Journal of Clinical Oncology, 05/20/09 Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status
British Journal of Haematology, 05/20/09 A minimally invasive surgical treatment possibility of osteolytic vertebral collapse in multiple myeloma
European Spine Journal, 05/19/09 Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms
Expert Review of Anticancer Therapy, 05/19/09 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma
Bone Marrow Transplantation, 05/19/09 Phase I-IIa multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(R), TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
Journal of Hematology & Oncology, 05/15/09
Free full text
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
Blood, 05/15/09 Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome
Cancer Genetics and Cytogenetics, 05/15/09 Kinase drug discovery approaches in chronic myeloproliferative disorders
Oncogene, 05/14/09 Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Annals of Hematology, 05/13/09 International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Leukemia, 05/13/09 Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing
British Journal of Haematology, 05/12/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
187 Available Pages
|
|
